Company: CGC
Filing Date: 2025-02-28
Form Type: 424B5
Source: 0001104659-25-019242
Chunk: 4

Company: Canopy Growth Corp
Filing Date: 2025-02-28
Form: 424B5
Chunk 4
---
 and the accompanying prospectus carefully (including the documents incorporated by reference herein and therein), especially the “Risk Factors” section beginning on page S-5, the “Risk Factors” section of the Annual Report and our subsequently filed Quarterly Reports on Form 10-Q, and in the other documents from time to time incorporated by reference herein, as well as our consolidated financial statements and the related notes incorporated by reference in this prospectus supplement and the accompanying prospectus, before deciding to invest in our Common Shares. You should also carefully read the information incorporated by reference into this prospectus supplement, including our financial statements, and the exhibits to the Registration Statement of which this prospectus supplement is a part. See “Cautionary Note Regarding Forward-Looking Statements.”

#### Our Company
We are a world-leading cannabis company which produces, distributes, and sells a diverse range of cannabis and cannabis-related products. Our cannabis products are principally sold for adult-use and medical purposes under a portfolio of distinct brands in Canada pursuant to the Cannabis Act , SC 2018, c 16, and globally pursuant to applicable international and Canadian legislation, regulations, and permits. Our core operations are in Canada, Europe (including Germany and Poland) and Australia.

#### Corporate Information
The Company’s principal executive offices are located at 1 Hershey Drive, Smiths Falls, Ontario, Canada, K7A 0A8. The Company maintains a website at www.canopygrowth.com. The information on, or otherwise accessible through, our website does not constitute a part of, and is not incorporated by reference into, this prospectus supplement.

<div align='center'>S-2</div>

TABLE OF CONTENTS

### THE OFFERING

#### Issuer
Canopy Growth Corporation

#### Common Shares Offered by us
Common Shares having an aggregate offering price of up to $200,000,000, less any amounts sold in Canada through the Concurrent Canadian Offering. The maximum offering size of this offering and the Concurrent Canadian Offering, taken together, will not exceed $200,000,000.

**Common Shares to be outstanding immediately after this offering and the Concurrent Canadian Offering (1)**

Up to 298,046,422 Common Shares, assuming an offering price of $1.41 per share, which was the last sale price of our Common Shares on the Nasdaq Global Select Market on February 27, 2025, and assuming no sales in the Concurrent Canadian Offering. The actual number of Common Shares issued will vary depending on the sales prices from time